SOPHiA GENETICS
SOPH
SOPH
34 hedge funds and large institutions have $70.4M invested in SOPHiA GENETICS in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.12% less ownership
Funds ownership: 33.89% → 33.77% (-0.12%)
58% less capital invested
Capital invested by funds: $167M → $70.4M (-$97.1M)
Holders
34
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$5.1M | |
| 2 | +$757K | |
| 3 | +$593K | |
| 4 |
Barclays
London,
United Kingdom
|
+$209K |
| 5 |
PVI
Pura Vida Investments
New York
|
+$109K |
Top Sellers
| 1 | -$4.53M | |
| 2 | -$2.22M | |
| 3 | -$1.75M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.37M |
| 5 |
Jennison Associates
New York
|
-$940K |